Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial
Top Cited Papers
- 7 May 2003
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 41 (9), 1438-1444
- https://doi.org/10.1016/s0735-1097(03)00241-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal DiseaseCirculation, 2002
- Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled studyEuropean Heart Journal, 2000
- Clinical relevance of cytokine production in hemodialysisKidney International, 2000
- Sympathetic Overactivity in Hypertensive Patients with Chronic Renal DiseaseThe New England Journal of Medicine, 1999
- Chronic Renal Failure — A Vasculopathic StateThe New England Journal of Medicine, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996
- End stage renal disease and dialysis reportNephrology Dialysis Transplantation, 1996
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- Sympathetic Overactivity in Patients with Chronic Renal FailureThe New England Journal of Medicine, 1992
- Myocardial Protection with CarvedilolJournal of Cardiovascular Pharmacology, 1992